Potential Coronavirus Vaccine Provides Momentum For Gilead Sciences
Potential Coronavirus Vaccine Provides Momentum For Gilead Sciences 3Gilead Sciences stock has been gaining momentum amidst the global coronavirus (COVID-19) outbreak. Remdesivir, a potential treatment for the coronavirus, is under trial and is largely welcomed by China. A potential acquisition of Forty Seven Inc. could create synergy with Gilead’s drug portfolio. Gilead Sciences (GILD) has risen to the market’s …
News story posted on 2020-03-05T15:05:00.0000000Z